Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

A treatment comparison of carfilzomib, dexamethasone and daratumumab to daratumumab and bortezomib

Prof Evangelos Terpos - University of Athens, Athens, Greece
A treatment comparison of carfilzomib, dexamethasone and daratumumab to daratumumab and bortezomib ( Prof Evangelos Terpos - University of Athens, Athens, Greece )
22 Dec 2020

Real-world evidence of the use of carfilzomib to refractory to lenalidomide patients

Prof Evangelos Terpos - University of Athens, Athens, Greece
Real-world evidence of the use of carfilzomib to refractory to lenalidomide patients ( Prof Evangelos Terpos - University of Athens, Athens, Greece )
22 Dec 2020

Real-world evidence of the use of carfilzomib among multiple myeloma patients across 10 European countries and Israel

Prof Evangelos Terpos - University of Athens, Athens, Greece
Real-world evidence of the use of carfilzomib among multiple myeloma patients across 10 European countries and Israel ( Prof Evangelos Terpos - University of Athens, Athens, Greece )
22 Dec 2020

2020 updates in treating NTRK fusion cancer

Dr Alexander Drilon and Prof Marc Peeters
2020 updates in treating NTRK fusion cancer ( Dr Alexander Drilon and Prof Marc Peeters )
22 Dec 2020

PARP inhibitors for prostate cancer: What oncology PAs should know

Colleen Tetzlaf, PA-C, Fox Chase Cancer Center, Philadelphia, USA
PARP inhibitors for prostate cancer: What oncology PAs should know ( Colleen Tetzlaf, PA-C, Fox Chase Cancer Center, Philadelphia, USA )
18 Dec 2020

ESMO 2020: New developments in the treatment of lung cancer

Dr Luis Raez - Memorial Cancer Institute, Miami, USA
ESMO 2020: New developments in the treatment of lung cancer ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )
17 Dec 2020

SABCS 2020: Conference roundup

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
SABCS 2020: Conference roundup ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
16 Dec 2020

PRWCC: Disease burden impacts outcomes in paediatric and young adult B-Cell ALL after commercial tisagenlecleucel

Dr Liora Schultz - Stanford University School of Medicine, Palo Alto, USA
PRWCC: Disease burden impacts outcomes in paediatric and young adult B-Cell ALL after commercial tisagenlecleucel ( Dr Liora Schultz - Stanford University School of Medicine, Palo Alto, USA )
16 Dec 2020

Researchers trace the origin of blood cancer to early childhood, decades before diagnosis

Dr Jyoti Nangalia - University of Cambridge, Cambridge, UK
Researchers trace the origin of blood cancer to early childhood, decades before diagnosis ( Dr Jyoti Nangalia - University of Cambridge, Cambridge, UK )
16 Dec 2020

Risk profiling of relapsed/refractory diffuse large B-cell lymphoma patients by measuring circulating tumour DNA

Dr Alex Herrera - City of Hope Comprehensive Cancer Center, Duarte, USA
Risk profiling of relapsed/refractory diffuse large B-cell lymphoma patients by measuring circulating tumour DNA ( Dr Alex Herrera - City of Hope Comprehensive Cancer Center, Duarte, USA )
15 Dec 2020

ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma

Dr Robert Rifkin, Prof Sagar Lonial, Prof Evangelos Terpos, Dr Nina Shah, Dr Eric Smith
ASH 2020:  Immunotherapy in relapsed/refractory multiple myeloma ( Dr Robert Rifkin, Prof Sagar Lonial, Prof Evangelos Terpos, Dr Nina Shah, Dr Eric Smith )
15 Dec 2020

Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the randomised Forte trial

Dr Francesca Gay - University of Torino, Torino, Italy
Survival analysis of newly diagnosed transplant-eligible multiple myeloma patients in the randomised Forte trial ( Dr Francesca Gay - University of Torino, Torino, Italy )
14 Dec 2020